Memorial Sloan Kettering Cancer Center

This study tests whether combining two drugs, ruxolitinib and thalidomide, can shrink the cancer and improve symptoms in people with myelofibrosis, a rare bone marrow disorder. About 30 adults with the disease, including those who have tried other treatments, will receive the com…

This large study is testing whether adding a radioactive drug called radium-223 to standard chemotherapy helps men with advanced prostate cancer that has stopped responding to hormone therapy. The goal is to see if the combination helps patients live longer than chemotherapy alon…

This study tests new ways to perform MRI scans that can reduce blurring caused by movement. Researchers will try different timing and computer processing methods in 21 children and adults already scheduled for an MRI. The goal is to see if these new techniques produce clearer ima…